Vaccination Approach for Adults Without Immunization Records

Core Principles

• The Centers for Disease Control and Prevention recommends that adults without documentation of vaccination should be assumed unvaccinated and receive all age-appropriate vaccines according to the current immunization schedule, as administering vaccines to previously immunized individuals poses no additional risk 1, 2
• The standard approach when vaccination records are unavailable is to administer indicated vaccines rather than attempting serologic testing for most vaccines, as giving an extra dose to someone already immune is safe and avoids delays in protection 3, 4

Essential Vaccines for All Adults

• The American College of Physicians recommends administering a complete 3-dose primary series of Tetanus-Diphtheria-Pertussis (Td/Tdap) if no documentation exists, with the first two doses at least 4 weeks apart and the third dose 6-12 months after the second 5, 6
• The Centers for Disease Control and Prevention recommends annual vaccination against influenza for all adults, regardless of age, with standard-dose inactivated vaccine for adults 18-64 years and high-dose or adjuvanted formulations for those ≥65 years 5, 7
• The Advisory Committee on Immunization Practices recommends universal vaccination against Hepatitis B for all adults aged 19-59 years, with a 2-dose series of HEPLISAV-B at 0 and 1 month or a 3-dose series of ENGERIX-B, Recombivax HB, or PreHevbrio at 0, 1, and 6 months 7

Age-Specific Vaccine Recommendations

• The American Academy of Family Physicians recommends that adults 19-49 years receive 1-2 doses of MMR if born in 1957 or later without documentation of vaccination, physician-diagnosed disease, or laboratory immunity, with 2 doses required for healthcare workers and other high-risk adults 5, 6
• The Centers for Disease Control and Prevention recommends that adults 50-64 years with high-risk conditions receive pneumococcal vaccination, and that all adults in this age group continue all core vaccines listed above 5, 8
• The National Foundation for Infectious Diseases recommends that adults ≥65 years receive pneumococcal vaccines, with PCV15, PCV20, or PCV21 followed by PPSV23 based on specific sequencing guidelines, and that they receive a 2-dose series of recombinant zoster vaccine (Shingrix) at 0 and 2-6 months 5, 7

Additional Risk-Based Vaccines

• The Centers for Disease Control and Prevention recommends a 2-dose series of Hepatitis A vaccine for men who have sex with men, injection drug users, individuals with chronic liver disease, travelers to endemic areas, and those with close contact with international adoptees 1, 2
• The Advisory Committee on Immunization Practices recommends that individuals with functional or anatomic asplenia, complement deficiencies, HIV infection, or who are microbiologists or travelers to endemic areas receive 2 doses of MCV4 (meningococcal conjugate vaccine) 2 months apart 1, 2

Critical Implementation Points

• The American College of Physicians recommends that when vaccines are indicated but status is uncertain, they should be administered immediately without waiting for records or serologic confirmation, prioritizing protection over theoretical concerns about redundant vaccination 1, 2, 8
• The Centers for Disease Control and Prevention recommends that patients with immunocompromising conditions complete all indicated vaccines at least 2 weeks before starting immunosuppressive therapy when possible, and that live vaccines be given at least 4 weeks before immunosuppression or deferred until immune function recovers 4, 8

Immunization Recommendations for Unvaccinated 19‑Year‑Old Adults

Core Vaccines

• The CDC ACIP recommends that after completing the primary Tdap/Td series, Td boosters be given every 10 years. [9][10]
• The CDC ACIP recommends an annual dose of inactivated or live‑attenuated influenza vaccine for all adults, regardless of age or risk factors. [9][11]
• For individuals born in 1957 or later with no documentation of measles, mumps, or rubella vaccination or laboratory evidence of immunity, a two‑dose MMR series spaced at least 4 weeks apart is required. [12][13]
• When no evidence of varicella immunity exists, a two‑dose varicella vaccine series given 4–8 weeks apart is recommended; evidence of immunity includes U.S. birth before 1980 (except health‑care personnel), documented vaccination, laboratory confirmation, or physician‑diagnosed disease. [12][10]
• The CDC ACIP recommends a three‑dose human papillomavirus (HPV) series (0, 1–2, 6 months) for males and females through age 26 years. For males, routine vaccination is through age 21 with catch‑up through 26. [9][12]14

Risk‑Based Vaccines

• A two‑dose hepatitis A vaccine series is indicated for adults with any of the following risk factors: men who have sex with men, injection or non‑injection drug use, chronic liver disease, homelessness, travel to endemic regions, or close contact with international adoptees. [12][11]14
• MenACWY (meningococcal conjugate) vaccine should be administered to individuals who live in college dormitories or military barracks, have functional or anatomic asplenia, or are microbiologists routinely exposed to Neisseria meningitidis. [12][10]11
• MenB (meningococcal B) vaccine may be considered for healthy adolescents and young adults aged 16–23 years (preferred 16–18) based on individual clinical decision; a two‑dose MenB‑4C series ≥ 1 month apart or a MenB‑FHbp series at 0 and 6 months is recommended, and the two products are not interchangeable. [12][10]

Implementation Considerations

• Serologic testing may be considered only for varicella in adults with uncertain history; otherwise, vaccination without testing is acceptable. 10
• Immunization records or laboratory evidence, not patient recall, are required to confirm immunity before withholding vaccines. [12][10]
• Live vaccines (MMR, varicella, LAIV) must not be administered to pregnant women or severely immunocompromised patients. [14][10]
• Health‑care workers should receive two doses of MMR and two doses of varicella vaccine regardless of birth year. [13][10]
• Pregnant individuals should receive a Tdap dose during each pregnancy at 27–36 weeks gestation. 10

Evidence‑Based Immunization Recommendations for Healthy Young Adults

Influenza Vaccination

• The CDC ACIP recommends that all adults receive one annual dose of an inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV).  [15][16]
• For healthy adults ≤ 49 years of age, a live‑attenuated influenza vaccine (LAIV) is an acceptable alternative. [15][16]

Human Papillomavirus (HPV) Vaccination

• A 3‑dose HPV series (0 months, 1–2 months, 6 months) is recommended for males and females up to age 26 years. [17][18]
• For males, routine vaccination is advised through age 21 years, with catch‑up vaccination permitted through age 26 years. 17
• The 3‑dose schedule is indicated when the series is initiated at age 15 years or older (i.e., the patient did not start before age 15). [17][18]19

Hepatitis A Vaccination

• A 2‑dose hepatitis A vaccine series should be offered to individuals with any of the following risk factors:
• Vaccination may also be given to persons without identified risk factors who simply desire protection against hepatitis A. [15][16]

Meningococcal B (MenB) Vaccination

• For healthy young adults aged 16–23 years (preferably 16–18 years), the CDC ACIP suggests individual clinical decision‑making regarding MenB vaccination.